Literature DB >> 27385010

Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.

Roman Szabo1, Taliya Lantsman1, Diane E Peters2, Thomas H Bugge3.   

Abstract

The membrane-anchored serine proteases prostasin (PRSS8) and matriptase (ST14) initiate a cell surface proteolytic pathway essential for epithelial function. Mice expressing only catalytically inactive prostasin are viable, unlike prostasin null mice, indicating that at least some prostasin functions are non-proteolytic. Here we used knock-in mice expressing catalytically inactive prostasin (Prss8(Ki/Ki)) to show that the physiological and pathological functions of prostasin vary in their dependence on its catalytic activity. Whereas prostasin null mice exhibited partial embryonic and complete perinatal lethality, Prss8(Ki/Ki) mice displayed normal prenatal and postnatal survival. Unexpectedly, catalytically inactive prostasin caused embryonic lethality in mice lacking its cognate inhibitors HAI-1 (SPINT1) or HAI-2 (SPINT2). Proteolytically inactive prostasin, unlike the wild-type protease, was unable to activate matriptase during placentation. Surprisingly, all essential functions of prostasin in embryonic and postnatal development were compensated for by loss of HAI-1, indicating that prostasin is only required for mouse development and overall viability in the presence of this inhibitor. This study expands our knowledge of non-proteolytic functions of membrane-anchored serine proteases and provides unexpected new data on the mechanistic interactions between matriptase and prostasin in the context of epithelial development.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cell surface proteolysis; Epithelial development; Placental labyrinth; Serine protease

Mesh:

Substances:

Year:  2016        PMID: 27385010      PMCID: PMC5004911          DOI: 10.1242/dev.137968

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  40 in total

1.  The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin.

Authors:  C L Scudamore; M A Jepson; B H Hirst; H R Miller
Journal:  Eur J Cell Biol       Date:  1998-04       Impact factor: 4.492

2.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Authors:  Karin List; Christian C Haudenschild; Roman Szabo; WanJun Chen; Sharon M Wahl; William Swaim; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

3.  Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.

Authors:  R Szabo; A Molinolo; K List; T H Bugge
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

4.  Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.

Authors:  Sarah Netzel-Arnett; Brooke M Currie; Roman Szabo; Chen-Yong Lin; Li-Mei Chen; Karl X Chai; Toni M Antalis; Thomas H Bugge; Karin List
Journal:  J Biol Chem       Date:  2006-09-15       Impact factor: 5.157

5.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

7.  Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Authors:  Koki Nagaike; Makiko Kawaguchi; Naoki Takeda; Tsuyoshi Fukushima; Akira Sawaguchi; Kazuyo Kohama; Mitsuru Setoyama; Hiroaki Kataoka
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

Authors:  Karin List; Roman Szabo; Philip W Wertz; Julie Segre; Christian C Haudenschild; Soo-Youl Kim; Thomas H Bugge
Journal:  J Cell Biol       Date:  2003-11-24       Impact factor: 10.539

9.  Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Authors:  Roman Szabo; Katiuchia Uzzun Sales; Peter Kosa; Natalia A Shylo; Sine Godiksen; Karina K Hansen; Stine Friis; J Silvio Gutkind; Lotte K Vogel; Edith Hummler; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

10.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8.

Authors:  Céline Leyvraz; Roch-Philippe Charles; Isabelle Rubera; Marjorie Guitard; Samuel Rotman; Bernadette Breiden; Konrad Sandhoff; Edith Hummler
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

View more
  18 in total

1.  Congenital sodium diarrhea and chorioretinal coloboma with optic disc coloboma in a patient with biallelic SPINT2 mutations, including p.(Tyr163Cys).

Authors:  Kristin E Hirabayashi; Anthony T Moore; Bryce A Mendelsohn; Ryan J Taft; Aditi Chawla; Denise Perry; Duncan Henry; Anne Slavotinek
Journal:  Am J Med Genet A       Date:  2018-04       Impact factor: 2.802

2.  Functional analysis of corin protein domains required for PCSK6-mediated activation.

Authors:  Shenghan Chen; Hao Wang; Heng Li; Yue Zhang; Qingyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2017-11-24       Impact factor: 5.085

3.  The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.

Authors:  Peizhong Mao; Aaron M Wortham; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2018-12-17       Impact factor: 5.157

4.  The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.

Authors:  Caroline A Enns; Shall Jue; An-Sheng Zhang
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

5.  Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.

Authors:  Anne Harbig; Marco Mernberger; Linda Bittel; Stephan Pleschka; Klaus Schughart; Torsten Steinmetzer; Thorsten Stiewe; Andrea Nist; Eva Böttcher-Friebertshäuser
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

6.  EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.

Authors:  Roman Szabo; Jerrold M Ward; Ferruh Artunc; Thomas H Bugge
Journal:  Biol Open       Date:  2022-07-11       Impact factor: 2.643

Review 7.  The spatiotemporal control of human matriptase action on its physiological substrates: a case against a direct role for matriptase proteolytic activity in profilaggrin processing and desquamation.

Authors:  Chen-Yong Lin; Jehng-Kang Wang; Michael D Johnson
Journal:  Hum Cell       Date:  2020-04-18       Impact factor: 4.174

8.  Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.

Authors:  Shiao-Pieng Lee; Chen-Yu Kao; Shun-Cheng Chang; Yi-Lin Chiu; Yen-Ju Chen; Ming-Hsing G Chen; Chun-Chia Chang; Yu-Wen Lin; Chien-Ping Chiang; Jehng-Kang Wang; Chen-Yong Lin; Michael D Johnson
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

9.  Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.

Authors:  Roman Szabo; LuLu K Callies; Thomas H Bugge
Journal:  Development       Date:  2019-11-18       Impact factor: 6.862

10.  Matriptase zymogen supports epithelial development, homeostasis and regeneration.

Authors:  Stine Friis; Daniel Tadeo; Sylvain M Le-Gall; Henrik Jessen Jürgensen; Katiuchia Uzzun Sales; Eric Camerer; Thomas H Bugge
Journal:  BMC Biol       Date:  2017-06-01       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.